Glaxosmithkline Plc (GSK)

 NULL
   
  • Closing Price Chg:
    $1.30
  • 52 Week High: NULL
  • 52 Week Low: $32.08
  • Currency: US Dollars
  • Shares Issued: 465.72m
  • Volume: 0
  • RiskGrade: 119
  • Beta: 0.25

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-25 Interim 15,502.00 3,995.00 75.30p 32.00p

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 34,099.00 6,968.00 115.90p 31.8 n/a -6% 80.00p 2.9%
31-Dec-21 24,696.00 3,599.00 90.56p 48.7 n/a -22% 80.00p 2.4%
31-Dec-22 29,324.00 5,628.00 139.70p 25.2 0.5 +54% 44.00p 1.7%
31-Dec-23 30,328.00 6,064.00 155.10p 23.9 2.2 +11% 58.00p 2.1%
31-Dec-24 31,376.00 3,477.00 159.30p 21.2 7.1 +3% 61.00p 2.4%

Forecasts

Forecasts data is not available for this company.

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 23.24 16.96 23.15 0.77

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency US Dollars
Share Price NULL
Closing Price Change $ 1.30
% Change 0.00 %
52 Week High NULL
52 Week Low $32.08
Volume 0
Shares Issued 465.72m
Beta 0.25
RiskGrade 119

Trades for --2025

Time Volume / Share Price
0 @ $0.00

GSK Key Personnel

CEO Emma Walmsley

Top of Page